Bioton has new CEO, main investor eyes biotech
WARSAW, Nov 7 (Reuters) - The Head of Poland's insulin maker Bioton BOTN.WA, Janusz Guy, has stepped down and will be replaced by Slawomir Ziegert, the company said in a statement late on Friday.
Bioton's main shareholder, Ryszard Krazue, said the resignation was due to private reasons and that the company was considering selling its antibiotics arm.
"The future lies in developing biotechnology," Krauze was quoted on Saturday by daily Parkiet as saying. "The cash obtained this way we could invest in selling highly profitable insulin or other biotech products."
Krauze added he had great hopes in regard to Ziegert and wanted the company's restructuring programme to be finalised by the end of the year. Bioton is to publish its third-quarter results on Nov.16. (Writing by Gabriela Baczynska)
© Thomson Reuters 2009 All rights reserved
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India during the Reuters India Investment Summit in Mumbai and Bangalore. Full Coverage | Blog
PLAYBOY SALE
An icon bows to changing times
With his Playboy Enterprises in talks to be sold for about $300 million, the 83 year-old Hugh Hefner will be giving up control over the iconic adult entertainment empire he founded that was instrumental in shaping society's opinions on nudity, sex and free speech. Full Article
India
US
UK
